SHIMLA, Feb. 12 -- Four drugs manufactured in Himachal Pradesh-based pharmaceutical companies have failed the Central Drugs Standards Control Organisation's (CDSCO) quality test.

The CDSCO issued an alert on Monday, saying the drugs that failed the test are Amoxycillin dispersible tablets IP 250mg; Theoimmune (pro-biotic capsules); Gabapentin tablets IP 300mg; and Depotex 16mg (Methylprednisolone tablets IP).

These drugs are used for treating obesity, mental illness, bacterial infection and arthritis.

Three of these drugs were manufactured in pharmaceutical companies in Nalagarh and Parwanoo of Solan district and one in a unit in Kangra district.

The CDSCO tested 1,177 samples in January. It issued an alert for 34 drugs in India that fa...